Literature DB >> 11466715

Response evaluation criteria in solid tumors (RECIST): new guidelines.

Y Tsuchida, P Therasse.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11466715     DOI： 10.1002/mpo.1154

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN： 0098-1532


× No keyword cloud information.
  64 in total

1.  Can paediatric radiologists resist RECIST (response evaluation criteria in solid tumours)?

Authors:  Kieran McHugh; Simon Kao
Journal:  Pediatr Radiol       Date:  2003-11

Review 2.  A review of the automated detection of change in serial imaging studies of the brain.

Authors:  Julia Patriarche; Bradley Erickson
Journal:  J Digit Imaging       Date:  2004-06-29       Impact factor: 4.056

3.  Part 1. Automated change detection and characterization in serial MR studies of brain-tumor patients.

Authors:  Julia Willamena Patriarche; Bradley James Erickson
Journal:  J Digit Imaging       Date:  2007-09       Impact factor: 4.056

4.  The effect of lung volume on nodule size on CT.

Authors:  Iva Petkovska; Matthew S Brown; Jonathan G Goldin; Hyun J Kim; Michael F McNitt-Gray; Fereidoun G Abtin; Raffi J Ghurabi; Denise R Aberle
Journal:  Acad Radiol       Date:  2007-04       Impact factor: 3.173

5.  Unresectable hepatocellular carcinoma: serial early vascular and cellular changes after transarterial chemoembolization as detected with MR imaging.

Authors:  Ihab R Kamel; Eleni Liapi; Diane K Reyes; Marianna Zahurak; David A Bluemke; Jean-François H Geschwind
Journal:  Radiology       Date:  2009-02       Impact factor: 11.105

Review 6.  Biomarkers in oncology drug development.

Authors:  Darren R Hodgson; Robin D Whittaker; Athula Herath; Dereck Amakye; Glen Clack
Journal:  Mol Oncol       Date:  2008-12-11       Impact factor: 6.603

7.  Acetylated tubulin (AT) as a prognostic marker in squamous cell carcinoma of the head and neck.

Authors:  Nabil F Saba; Kelly R Magliocca; Sungjin Kim; Susan Muller; Zhengjia Chen; Taofeek K Owonikoko; Nicholas J Sarlis; Carrie Eggers; Vanessa Phelan; William J Grist; Amy Y Chen; Suresh S Ramalingam; Zhuo G Chen; Jonathan J Beitler; Dong M Shin; Fadlo R Khuri; Adam I Marcus
Journal:  Head Neck Pathol       Date:  2013-07-24

8.  Gemcitabine Combined with the mTOR Inhibitor Temsirolimus in Patients with Locally Advanced or Metastatic Pancreatic Cancer. A Hellenic Cooperative Oncology Group Phase I/II Study.

Authors:  Vasilios Karavasilis; Epaminontas Samantas; Georgia-Angeliki Koliou; Anna Kalogera-Fountzila; George Pentheroudakis; Ioannis Varthalitis; Helena Linardou; Grigorios Rallis; Maria Skondra; Georgios Papadopoulos; George Papatsibas; Joseph Sgouros; Athina Goudopoulou; Konstantine T Kalogeras; Christos Dervenis; Dimitrios Pectasides; George Fountzilas
Journal:  Target Oncol       Date:  2018-12       Impact factor: 4.493

9.  Single-center phase II trial of transarterial chemoembolization with drug-eluting beads for patients with unresectable hepatocellular carcinoma: initial experience in the United States.

Authors:  Diane K Reyes; Josephina A Vossen; Ihab R Kamel; Nilofer S Azad; Tamara A Wahlin; Michael S Torbenson; Michael A Choti; Jean-Francois H Geschwind
Journal:  Cancer J       Date:  2009 Nov-Dec       Impact factor: 3.360

10.  Correlation analysis of oral lesion sizes by various standardized criteria.

Authors:  Carrie E Flanagan; Nelson L Rhodus; Kate A Cole; Eva Szabo; Frank G Ondrey
Journal:  Am J Otolaryngol       Date:  2016-07-12       Impact factor: 1.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.